Are we close to targeted treatments for Huntington’s disease? NO


Authors: doc. MUDr. Marek Baláž, Ph.D.
Authors‘ workplace: I. neurologická klinika LF MU ;  FN u sv. Anny v Brně
Published in: Cesk Slov Neurol N 2020; 83/116(3): 241
Category: Controversions


Sources

1. Ustohal L, Obdržálková M, Víchová M. Huntingtonova choroba jako neuropsychiatrický problém. Psychiatr praxi 2018; 19 (2): 64–66.

2. Wild EJ, Tabrizi SJ. One decade ago, one decade ahead in huntington‘s disease. Mov Disord 2019; 34 (10): 1434–1439. doi: 10.1002/mds.27849.

3. Testa CM, Jankovic J. Huntington disease: a quarter century of progress since the gene discovery. J Neurol Sci 2019; 396: 52–68. doi: 10.1016/j.jns.2018.09.022.

4. Travessa AM, Rodrigues FB, Mestre TA et al. Fifteen years of clinical trials in Huntington‘s disease: a very low clinical drug development success rate. J Huntingtons Dis 2017; 6 (2): 157–163. doi: 10.3233/JHD-170245.

Labels
Paediatric neurology Neurosurgery Neurology

Article was published in

Czech and Slovak Neurology and Neurosurgery

Issue 3

2020 Issue 3

Most read in this issue

This topic is also in:


Login
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account